USD
$0.00
(0.00%
)At Close (As of Oct 16, 2025)
$231.95B
Market Cap
16.47
P/E Ratio
8.09
EPS
$139.33
52 Week High
$109.21
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $21B |
Total Revenue | $42B |
Cost Of Revenue | $21B |
Costof Goods And Services Sold | $21B |
Operating Income | $6.8B |
Selling General And Administrative | $12B |
Research And Development | $2.8B |
Operating Expenses | $14B |
Investment Income Net | - |
Net Interest Income | -$215M |
Interest Income | $344M |
Interest Expense | $603M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $3.2B |
Income Before Tax | $7B |
Income Tax Expense | -$6.4B |
Interest And Debt Expense | - |
Net Income From Continuing Operations | $13B |
Comprehensive Income Net Of Tax | - |
Ebit | $7.6B |
Ebitda | $11B |
Net Income | $13B |
Field | Value (USD) |
---|---|
Total Assets | $81B |
Total Current Assets | $24B |
Cash And Cash Equivalents At Carrying Value | $7.6B |
Cash And Short Term Investments | $7.6B |
Inventory | $6.2B |
Current Net Receivables | $6.9B |
Total Non Current Assets | $58B |
Property Plant Equipment | $12B |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $6.6B |
Intangible Assets Excluding Goodwill | $6.6B |
Goodwill | $23B |
Investments | - |
Long Term Investments | $886M |
Short Term Investments | $351M |
Other Current Assets | $2.6B |
Other Non Current Assets | - |
Total Liabilities | $34B |
Total Current Liabilities | $14B |
Current Accounts Payable | $4.2B |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $1.8B |
Total Non Current Liabilities | $19B |
Capital Lease Obligations | $896M |
Long Term Debt | $13B |
Current Long Term Debt | $1.5B |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $15B |
Other Current Liabilities | $7.6B |
Other Non Current Liabilities | $3.4B |
Total Shareholder Equity | $48B |
Treasury Stock | - |
Retained Earnings | $47B |
Common Stock | $25B |
Common Stock Shares Outstanding | $1.7B |
Field | Value (USD) |
---|---|
Operating Cashflow | $8.6B |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $3.2B |
Capital Expenditures | $2.2B |
Change In Receivables | - |
Change In Inventory | -$58M |
Profit Loss | - |
Cashflow From Investment | -$2.3B |
Cashflow From Financing | -$5.4B |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | $3.8B |
Dividend Payout Common Stock | $3.8B |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | -$1.3B |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | $13B |
Field | Value (USD) |
---|---|
Gross Profit | $21B |
Total Revenue | $42B |
Cost Of Revenue | $21B |
Costof Goods And Services Sold | $21B |
Operating Income | $6.8B |
Selling General And Administrative | $12B |
Research And Development | $2.8B |
Operating Expenses | $14B |
Investment Income Net | - |
Net Interest Income | -$215M |
Interest Income | $344M |
Interest Expense | $603M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $3.2B |
Income Before Tax | $7B |
Income Tax Expense | -$6.4B |
Interest And Debt Expense | - |
Net Income From Continuing Operations | $13B |
Comprehensive Income Net Of Tax | - |
Ebit | $7.6B |
Ebitda | $11B |
Net Income | $13B |
Field | Value |
---|---|
Ex Dividend Date | 2025-10-15 |
Declaration Date | 2025-09-19 |
Record Date | 2025-10-15 |
Payment Date | 2025-11-17 |
Amount | 0.59 |
Sector: HEALTHCARE
Industry: MEDICAL DEVICES
Abbott Laboratories (ABT) is a prominent American multinational healthcare company based in Abbott Park, Illinois, with expertise across a diverse range of sectors, including medical devices, diagnostics, nutritional products, and branded generic medicines. Established in 1888, Abbott has demonstrated a strong commitment to innovation, enhancing health outcomes through cutting-edge technology and comprehensive healthcare solutions. The company's strategic decision to spin off its research-based pharmaceutical operations into AbbVie in 2013 has allowed it to focus on its core offerings while maintaining a legacy of excellence in healthcare. With a robust global presence, Abbott is well-positioned to capitalize on emerging market opportunities and address evolving healthcare needs.